Protection Against Severe Clinical Outcomes With Adenovirus or Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Patients Hospitalized With Coronavirus Disease 2019

J Infect Dis. 2022 Sep 13;226(5):938-940. doi: 10.1093/infdis/jiac256.

Josep M Llibre^{1

2}, Boris Revollo^{1

2}, Sergi Aguilar³, Cristina Calomarde-Gomez⁴, Andreu Bruguera⁵, Raquel Martin-Iguacel^{5

6}

¹ Infectious Diseases Division, University Hospital Germans Trias, Badalona, Spain.
² Fight AIDS and Infectious Diseases Foundation, Badalona, Spain.
³ Internal Medicine, University Hospital Germans Trias, Badalona, Spain.
⁴ Rheumatology Department, University Hospital Germans Trias, Badalona, Spain.
⁵ Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Badalona, Spain.
⁶ Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.

No abstract available

Publication types